These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 3495000

  • 21. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
    Youngster SK, Nicklas WJ, Heikkila RE.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565
    [Abstract] [Full Text] [Related]

  • 22. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y, Mash D, Zhang SH, Stein I.
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [Abstract] [Full Text] [Related]

  • 23. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I, Langston JW.
    Life Sci; 1985 Jan 21; 36(3):207-12. PubMed ID: 3871240
    [Abstract] [Full Text] [Related]

  • 24. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B.
    Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC.
    J Neurochem; 1985 Oct 21; 45(4):1049-54. PubMed ID: 3928814
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Difference in monoamine oxidase B activity between C57 black and albino NMRI mouse strains may explain differential effects of the neurotoxin MPTP.
    Zimmer J, Geneser FA.
    Neurosci Lett; 1987 Aug 05; 78(3):253-8. PubMed ID: 3498133
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1988 Nov 05; 247(2):531-5. PubMed ID: 3141609
    [Abstract] [Full Text] [Related]

  • 31. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
    Kalaria RN, Harik SI.
    J Neurochem; 1987 Nov 05; 49(5):1589-94. PubMed ID: 3117975
    [Abstract] [Full Text] [Related]

  • 32. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Nov 05; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1987 Feb 05; 240(2):415-20. PubMed ID: 3100775
    [Abstract] [Full Text] [Related]

  • 36. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Pileblad E, Carlsson A.
    Pharmacol Toxicol; 1988 Apr 05; 62(4):213-22. PubMed ID: 3260379
    [Abstract] [Full Text] [Related]

  • 37. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
    Ottoboni S, Caldera P, Trevor A, Castagnoli N.
    J Biol Chem; 1989 Aug 15; 264(23):13684-8. PubMed ID: 2788162
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Da Prada M, Kettler R, Keller HH, Bonetti EP, Imhof R.
    Adv Neurol; 1987 Aug 15; 45():175-8. PubMed ID: 2881442
    [No Abstract] [Full Text] [Related]

  • 40. High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase.
    Parsons B, Rainbow TC.
    Eur J Pharmacol; 1984 Jul 13; 102(2):375-7. PubMed ID: 6332739
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.